Vitamin E in Retrolental Fibroplasia

Ian J. Smith, M. F.G. Buchanan, I. Goss, P. J. Congdon, Helen M. Hittner, Frank L. Kretzer, Arnold J. Rudolph, M. E.Blair Holbein, Gloria Troendle, Solomon Sobel

Research output: Contribution to journalLetter

9 Citations (Scopus)

Abstract

To the Editor: After the report of Hittner et al. (Dec. 3, 1981, issue)1 on the use of vitamin E in the prevention of retrolental fibroplasia, regular intramuscular injections of vitamin E were given here to all babies weighing less than 1500 g at birth who needed supplemental oxygen.2 , 3 Vitamin E (Ephynal, Roche) was given as a single intramuscular dose (25 mg per kilogram of body weight per day) daily until feedings were tolerated, and then 100 mg per kilogram per day was given orally. This preparation was obtained on a named-patient basis. All intramuscular injections were given into the.

Original languageEnglish (US)
Pages (from-to)669-670
Number of pages2
JournalNew England Journal of Medicine
Volume309
Issue number11
DOIs
StatePublished - Sep 15 1983

Fingerprint

Retinopathy of Prematurity
Vitamin E
Intramuscular Injections
Tocopherols
Body Weight
Parturition

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Smith, I. J., Buchanan, M. F. G., Goss, I., Congdon, P. J., Hittner, H. M., Kretzer, F. L., ... Sobel, S. (1983). Vitamin E in Retrolental Fibroplasia. New England Journal of Medicine, 309(11), 669-670. https://doi.org/10.1056/NEJM198309153091119

Vitamin E in Retrolental Fibroplasia. / Smith, Ian J.; Buchanan, M. F.G.; Goss, I.; Congdon, P. J.; Hittner, Helen M.; Kretzer, Frank L.; Rudolph, Arnold J.; Holbein, M. E.Blair; Troendle, Gloria; Sobel, Solomon.

In: New England Journal of Medicine, Vol. 309, No. 11, 15.09.1983, p. 669-670.

Research output: Contribution to journalLetter

Smith, IJ, Buchanan, MFG, Goss, I, Congdon, PJ, Hittner, HM, Kretzer, FL, Rudolph, AJ, Holbein, MEB, Troendle, G & Sobel, S 1983, 'Vitamin E in Retrolental Fibroplasia', New England Journal of Medicine, vol. 309, no. 11, pp. 669-670. https://doi.org/10.1056/NEJM198309153091119
Smith IJ, Buchanan MFG, Goss I, Congdon PJ, Hittner HM, Kretzer FL et al. Vitamin E in Retrolental Fibroplasia. New England Journal of Medicine. 1983 Sep 15;309(11):669-670. https://doi.org/10.1056/NEJM198309153091119
Smith, Ian J. ; Buchanan, M. F.G. ; Goss, I. ; Congdon, P. J. ; Hittner, Helen M. ; Kretzer, Frank L. ; Rudolph, Arnold J. ; Holbein, M. E.Blair ; Troendle, Gloria ; Sobel, Solomon. / Vitamin E in Retrolental Fibroplasia. In: New England Journal of Medicine. 1983 ; Vol. 309, No. 11. pp. 669-670.
@article{e9b55e09ee444cb19e63d48be58c9e6e,
title = "Vitamin E in Retrolental Fibroplasia",
abstract = "To the Editor: After the report of Hittner et al. (Dec. 3, 1981, issue)1 on the use of vitamin E in the prevention of retrolental fibroplasia, regular intramuscular injections of vitamin E were given here to all babies weighing less than 1500 g at birth who needed supplemental oxygen.2 , 3 Vitamin E (Ephynal, Roche) was given as a single intramuscular dose (25 mg per kilogram of body weight per day) daily until feedings were tolerated, and then 100 mg per kilogram per day was given orally. This preparation was obtained on a named-patient basis. All intramuscular injections were given into the.",
author = "Smith, {Ian J.} and Buchanan, {M. F.G.} and I. Goss and Congdon, {P. J.} and Hittner, {Helen M.} and Kretzer, {Frank L.} and Rudolph, {Arnold J.} and Holbein, {M. E.Blair} and Gloria Troendle and Solomon Sobel",
year = "1983",
month = "9",
day = "15",
doi = "10.1056/NEJM198309153091119",
language = "English (US)",
volume = "309",
pages = "669--670",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "11",

}

TY - JOUR

T1 - Vitamin E in Retrolental Fibroplasia

AU - Smith, Ian J.

AU - Buchanan, M. F.G.

AU - Goss, I.

AU - Congdon, P. J.

AU - Hittner, Helen M.

AU - Kretzer, Frank L.

AU - Rudolph, Arnold J.

AU - Holbein, M. E.Blair

AU - Troendle, Gloria

AU - Sobel, Solomon

PY - 1983/9/15

Y1 - 1983/9/15

N2 - To the Editor: After the report of Hittner et al. (Dec. 3, 1981, issue)1 on the use of vitamin E in the prevention of retrolental fibroplasia, regular intramuscular injections of vitamin E were given here to all babies weighing less than 1500 g at birth who needed supplemental oxygen.2 , 3 Vitamin E (Ephynal, Roche) was given as a single intramuscular dose (25 mg per kilogram of body weight per day) daily until feedings were tolerated, and then 100 mg per kilogram per day was given orally. This preparation was obtained on a named-patient basis. All intramuscular injections were given into the.

AB - To the Editor: After the report of Hittner et al. (Dec. 3, 1981, issue)1 on the use of vitamin E in the prevention of retrolental fibroplasia, regular intramuscular injections of vitamin E were given here to all babies weighing less than 1500 g at birth who needed supplemental oxygen.2 , 3 Vitamin E (Ephynal, Roche) was given as a single intramuscular dose (25 mg per kilogram of body weight per day) daily until feedings were tolerated, and then 100 mg per kilogram per day was given orally. This preparation was obtained on a named-patient basis. All intramuscular injections were given into the.

UR - http://www.scopus.com/inward/record.url?scp=0020621781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020621781&partnerID=8YFLogxK

U2 - 10.1056/NEJM198309153091119

DO - 10.1056/NEJM198309153091119

M3 - Letter

C2 - 6688460

AN - SCOPUS:0020621781

VL - 309

SP - 669

EP - 670

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 11

ER -